Unknown

Dataset Information

0

Prospective study of vaginal dilator use adherence and efficacy following radiotherapy.


ABSTRACT: Vaginal stenosis (VS) after pelvic radiotherapy (RT) can impair long-term quality of life. We prospectively assessed adherence and efficacy of vaginal dilator (VD) use in women after pelvic RT.Women with gastrointestinal (n=63) and gynecologic (n=46) cancers self-reported use and VD size in monthly diaries for 12months after radiotherapy. Adherence was measured as actual VD use out of recommended times over 12months (3×/week×52weeks=156).Among 109 participants, aged 28-81years (median, 58years), mean percent adherence over 12months was 42% (95% confidence interval [CI], 36-48%). Adherence was highest in the first quarter (56%), but fell to 25% by the fourth. Disease type, treatment sequence, and chemotherapy were predictors of adherence (all P<.05). Eighty-two percent maintained pre-RT VD size at 12months; of 49% with a decrease in VD size at 1month post-RT, 71% returned to pre-RT VD size at 12months. Disease type, younger age, and increased adherence at 6months were associated with maintaining or returning to pre-RT size at 12months (all P?.05).VD use is effective in minimizing VS, but adherence at 12months was poor. Studies evaluating methods of improving adherence and determining the optimal frequency and duration of use are needed.

SUBMITTER: Law E 

PROVIDER: S-EPMC5028178 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prospective study of vaginal dilator use adherence and efficacy following radiotherapy.

Law Ethel E   Kelvin Joanne F JF   Thom Bridgette B   Riedel Elyn E   Tom Ashlyn A   Carter Jeanne J   Alektiar Kaled M KM   Goodman Karyn A KA  

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20150708 1


<h4>Background and purpose</h4>Vaginal stenosis (VS) after pelvic radiotherapy (RT) can impair long-term quality of life. We prospectively assessed adherence and efficacy of vaginal dilator (VD) use in women after pelvic RT.<h4>Material and methods</h4>Women with gastrointestinal (n=63) and gynecologic (n=46) cancers self-reported use and VD size in monthly diaries for 12months after radiotherapy. Adherence was measured as actual VD use out of recommended times over 12months (3×/week×52weeks=156  ...[more]

Similar Datasets

| S-EPMC7944435 | biostudies-literature
| S-EPMC9238131 | biostudies-literature
| S-EPMC8191143 | biostudies-literature
| S-EPMC4653048 | biostudies-literature
| S-EPMC3555916 | biostudies-other
| S-EPMC5972244 | biostudies-literature
| S-EPMC8258551 | biostudies-literature
| S-EPMC8225894 | biostudies-literature
| S-EPMC7220839 | biostudies-literature
| S-EPMC6289009 | biostudies-literature